Can ancient Chinese meds yield novel drug leads? GSK thinks so
This article was originally published in Scrip
Executive Summary
While the Chinese government has recently been encouraging domestic pharmaceutical companies to develop traditional Chinese medicines (TCMs) as an area where they might compete internationally, some multinationals also appear to be looking at the same field, albeit in a different way.